1 AUGUST

NEW ZEALAND GAZETTE

2431

Podophyllum peltatum; for external use for the treatment
of warts other than anogenital warts in medicines
containing 10% or less of podophyllin

Podophyllotoxin; for external use for the treatment of
warts other than anogenital warts in medicines
containing 0.5% or less

Potassium chlorate; except in medicines containing 10% or
less

Prilocaine; for dermal use in medicines containing 10% or
less

Pyrithione zinc; for external use in medicines containing
more than 2%

Sabadilla; in packs containing 18 milligrams or less of total
alkaloids except in packs containing 1.8 milligrams or
less and a recommended daily dose of not more than
0.6 milligrams of total alkaloids

Silver; except in oral solutions containing 0.3% or less or
other medicines containing 1% or less

Silver sulfadiazine; for external use in packs containing
50 grams or less

Medicines for General Sale

Please note that the following medicines are no longer
classified as prescription medicines, restricted medicines or
pharmacy-only medicines. As such, they are now available
for general sale.

Aciclovir; for external use for the treatment of herpes
labialis except in except in medicines containing 5% or
less and tubes containing 3 grams or less

Bamyphylline

Benzamine

Benzyl benzoate

Bifonazole; for external use in medicines for tinea pedis
only or in shampoos containing 1% or less

Butyl aminobenzoate; in medicines for dermal use
containing 2% or less

Dichlofenthion

Diprophylline

Folic acid; in medicines containing 500 micrograms or less
per recommended daily dose

Folinic acid; in medicines containing 500 micrograms or
less per recommended daily dose

Gadobutrol

Guaiphenesin; for oral use in medicines containing 2% or
less or 200 milligrams or less

Mandelic acid

Monosulfiram

Reproterol

Sabadilla; in packs containing 1.8 milligrams or less with a
recommended daily dose of not more than 0.6 of total
alkaloids

Salicylic acid; in medicines containing 40% or less

Silver; in oral solutions containing 0.3% or less or other
medicines containing 1% or less

Terebene

Tetrastarch

Dated this 25th day of July 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation
(pursuant to delegation given by the Minister of Health
on the 20th day of February 1997).

Regulation 20 of the Medicines Regulations 1984 requires that all
medicines sold without a practitioner’s prescription must include a consumer
information panel on the label. Further, all material changes to a medicine
(including changes to labelling), must be notified to the Director-General of
Health in accordance with section 24 of the Medicines Act 1981.

go5062

Misuse of Drugs Act 1975

Medical Practitioners Who May Prescribe,

Administer, or Supply Controlled Drugs
for the Purpose of Treating People With
Drug Dependence

Pursuant to section 24 (5) (a) of the Misuse of Drugs Act
1975, I, David George Chaplow, acting under delegated
authority from the Minister of Health, specify that:

Dr Elizabeth Louise Draper, 266 Mt Pleasant Road,
Mt Pleasant, Christchurch

is a medical practitioner who may prescribe, administer, or
supply controlled drugs for the purposes of that section, with
the following conditions:

(a) Dr Draper’s prescribing of controlled drugs for
the treatment of opioid dependence is limited to
methadone;

(b) The prescription of methadone for the treatment
of dependence is limited to patients registered at
Dr Draper’s practice who have been assessed
as requiring methadone treatment for opioid
dependence by a gazetted methadone service; and

(c) Dr Draper’s authorisation of other medical
practitioners to prescribe controlled drugs for
the treatment of opioid dependence is limited to
designated locums working in her practice. Those
medical practitioners authorised by Dr Draper
may only prescribe controlled drugs for the
treatment of opioid dependence to patients registered
at Dr Draper’s practice and may only do so with
Dr Draper’s written permission.\n
Dated at Wellington this 24th day of July 2002.

DR DAVID CHAPLOW, Director of Mental Health.

go5035

Medical Practitioners Who May Prescribe,

Administer, or Supply Controlled Drugs
for the Purpose of Treating People With
Drug Dependence

Pursuant to section 24 (5) (a) of the Misuse of Drugs Act
1975, I, David George Chaplow, acting under delegated
authority from the Minister of Health, specify that:

Dr Jonathan Andrew Dowling Whitty, Ferry Road
Medical Centre, 276 Ferry Road, Christchurch

is a medical practitioner who may prescribe, administer, or
supply controlled drugs for the purposes of that section, with
the following conditions:

(a) Dr Whitty’s prescribing of controlled drugs for the
treatment of opioid dependence is limited to
methadone;

(b) The prescription of methadone for the treatment
of dependence is limited to patients registered at
Dr Whitty’s practice who have been assessed
as requiring methadone treatment for opioid
dependence by a gazetted methadone service; and

(c) Dr Whitty’s authorisation of other medical
practitioners to prescribe controlled drugs for
the treatment of opioid dependence is limited to
designated locums working in his practice. Those
medical practitioners authorised by Dr Whitty
may only prescribe controlled drugs for